Meetings & Events

Intellectual property terms are a key component of university-industry partnerships. Foreground Intellectual Property (FIP) meaning potentially patentable inventions may be conceived and reduced to practice during performance of an industry sponsored research agreement. Negotiation of the FIP clauses helps to assure that the parties understand each other’s expectations regarding the probability of FIP, access to, use and control of it to enable commercialization or further development as appropriate.

This session will address various aspects of defining and allocating right in foreground intellectual property along with practical considerations and related in a sponsored research agreement.

Who Should Attend?

This is an advanced-level webinar intended for audiences with working knowledge of intellectual property. This session is targeted to experienced corporate and academic representatives with responsibility for identifying, assessing, reviewing, negotiating, or managing intellectual property terms in university-company research contracts including representatives of technology transfer, sponsored projects, economic development, university relations/business relations, researchers and research staff.

Pricing

Foreground Intellectual Property Webinar
Member: $150 / Non-member: $300

10-Webinar Series
Member: $900 / Non-member: $1,900

See the full UIDP Contracting Webinar Series schedule here.

Contributors

Dava Casoni

Contracts and Compliance Advisor | USC Institute for Creative Technologies

Dava Casoni is a legal advisor to University of Southern California’s Institute for Creative Technologies, focusing on contracts, export controls, intellectual property and sponsored research and is serving her fourth term as an appointed member of State Department’s DTAG. Previously, Dava was associated with Bingham McCutchen, Pillsbury and Milbank Tweed, where she guided companies from start-up to initial public offerings and represented Fortune 500 companies on complex transactions. She also served as a U.S. Court of Federal Claims clerk to the Honorable James Turner and taught entertainment law at American University. She earned a B.A. and B.S. from Boston University and a J.D. and LL.M from Cornell Law School.

Heather Walsh

Director of External Innovation | Baxter International, Inc.

Heather Walsh is the Director of External Innovation and leads Baxter’s efforts to increase open innovation partnerships across universities, incubators/accelerators, medical centers, and other partners. She supports strategically-aligned transformational innovation for all the global business units and for technology platforms. She previously led technical assessment teams for due diligence of new opportunities for mergers and acquisitions and venture investment at Baxter. She joined Baxter from the University of Chicago, where she was the Assistant Director and Head of Business Development in the Technology Commercialization and Licensing group, at the Polsky Center for Entrepreneurship and Innovation. She spent nine years developing, protecting, and licensing University-owned intellectual property. In addition to her technology portfolio, Heather supported the efforts of the commercialization team by identifying and managing high-value contacts, coordinating the university’s marketing strategy for the opportunity pipeline, representing the team at multiple partnering meetings throughout each year, and launching a program to cultivate relationships with venture capital groups. She piloted and grew a proof-of-concept fund, redesigned the Polsky Accelerator program and launched several internship programs to leverage the talents of students and postdocs exploring alternative careers. Heather completed a PhD in Neurobiology, Pharmacology & Cell Physiology from the University of Chicago.

Moderator

Keith Spencer

Director, Academic Liaison | GSK

Keith joined GSK in 2016 and leads the US Academic Liaison Team at GSK, based just outside Philadelphia at one of GSK’s 2 global R&D Hubs. At GSK, Keith is responsible for putting in place agreements to facilitate collaborations with US academic institutions and other global academic centers. Keith also works to find opportunities to improve and expand GSK’s search for innovative science and talent. Prior to GSK, Keith was at the global research charity, Wellcome Trust, where he was part of the Innovations team which financed a broad range of healthcare opportunities and managed a portfolio of projects worth over $130M. Keith trained as an organic chemist, and obtained his PhD at the University of Oxford. After a postdoc at the University of Pennsylvania, he spent 10 years in the biotech sector at Arrow Therapeutics and co-founded re:Viral, a UK-based biotech.

About the Series

UIDP Academy presents a ten-part webinar series on contemporary issues and opportunities for effective negotiation of industry-sponsored research agreements (ISRAs). This series is strategically designed to offer seasoned contracting professionals, as well as novices and others who just want to learn more about the general issues affecting ISRA negotiations, an opportunity to discuss a broad range of contracting matters.

Information and ideas from leading subject matter experts are presented on tried, true, and new approaches, with opportunities for Q&A and presenter interaction. When appropriate, presenters will use the UIDP Contract Accords as practical guidance to help participants understand issues and collaborate more effectively.